Possible inhibitory effects of promotion stage treatment with thymosin fraction 5 on N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary tract carcinogenesis in NON/Shi mice

International Journal of Oncology

Volumn 8, Issue 1, 1996, Pages 117-124

  Murai, Takashi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

N butyl N (4 hydroxybutyl)nitrosamine; NON Shi mice; thymosin fraction 5; urinary tract carcinogenesis

Indexed keywords

N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; THYMOSIN FRACTION 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CARCINOGENESIS; CANCER INHIBITION; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR PROMOTION;

EID: 0030034177     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.1.117     Document Type: Article

References (3)

1. Tri vers GE and Goldstein AL: The endocrine thymus: A role for thymosin and other thymic factors in cancer immunity and therapy. Cancer B iol Rev 1: 49-131, 1980.
2. Asakawa M, Kinoshita Y, Kimura S, Hato F, Wada S, Nishijima T, Kishimoto T and Maekawa M: Restorative effects of thymosin fraction 5 on reduction in responsivcness of rat thymocytes to allogenic lymphocytes during bladder tumor induction. Cell Mol Biol 36: 265-274, 1990.
3. Wada S, Kinoshita Y, Ozaki Y, Nishio S, Kimura S and Maekawa M: Reduction in responsiveness of thymocytes to phytohemagglutinin during bladder tumor induction and restorative effects of thymosin fraction 5 in rats. J Natl Cancer Inst 78: 303-306, 1987.